Literature DB >> 7575743

Myocardial effects of flavonoids from Crataegus species.

M Schüssler1, J Hölzl, U Fricke.   

Abstract

The influence of the main flavonoids from Crataegus species (hawthorn, Rosaceae) on coronary flow, heart rate and left ventricular pressure as well as on the velocity of contraction and relaxation was investigated in Langendorff perfused isolated guinea pig hearts at a constant pressure of 70 cmH2O. Drug action was evaluated in a concentration range of 10(-7) to 5 x 10(-4) mol/l. An increase of coronary flow caused by the O-glycosides luteolin-7-glucoside (186%), hyperoside (66%) and rutin (66%) as well as an increase of the relaxation velocity (positive lusitropism) by luteolin-7-glucoside (104%), hyperoside (62%) and rutin (73%) were the major effects observed at a maximum concentration of 0.5 mmol/l. Furthermore, slight positive inotropic effects and a rise in heart rate were seen. Similar but less intensive actions were found with the C-glycosides vitexin, vitexin-rhamnoside and monoacetyl-vitexin-rhamnoside. Possible beta-adrenergic activities of the flavonoids could be excluded by the addition of propranolol in fixed concentrations of 10(-8) to 10(-5) mol/l. Moreover, pretreatment of the animals with reserpine (7 mg/kg) did not influence myocardial activity of hyperoside (10(-4) mol/l). As previous experiments showed an inhibition of the 3',5'-cyclic adenosine monophosphate phosphodiesterase, the results suggest an inhibition of this enzyme as the possible underlying mechanism of cardiac action of flavonoids from Crataegus species.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575743

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  13 in total

1.  Hawthorn (Crataegus monogyna Jacq.) extract exhibits atropine-sensitive activity in a cultured cardiomyocyte assay.

Authors:  Satin Salehi; Shannon R Long; Philip J Proteau; Theresa M Filtz
Journal:  J Nat Med       Date:  2008-08-12       Impact factor: 2.343

2.  Protective action of hydroxyethyl rutosides on singlet oxygen challenged cardiomyocytes.

Authors:  H G Olbrich; P Grabisch; A Grossmann; T Rinne; H Klepzig; E Mutschler
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  Protective effects of red wine polyphenolic compounds on the cardiovascular system.

Authors:  W Zenebe; O Pechánová; I Bernátová
Journal:  Exp Clin Cardiol       Date:  2001

Review 4.  Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review.

Authors:  Joanna Nawrot; Justyna Gornowicz-Porowska; Jaromir Budzianowski; Gerard Nowak; Grzegorz Schroeder; Joanna Kurczewska
Journal:  Cells       Date:  2022-06-11       Impact factor: 7.666

5.  Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial.

Authors:  Suzanna M Zick; Bonnie Motyka Vautaw; Brenda Gillespie; Keith D Aaronson
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534

Review 6.  Adverse-event profile of Crataegus spp.: a systematic review.

Authors:  Claudia Daniele; Gabriela Mazzanti; Max H Pittler; Edzard Ernst
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

7.  Role of natural herbs in the treatment of hypertension.

Authors:  Nahida Tabassum; Feroz Ahmad
Journal:  Pharmacogn Rev       Date:  2011-01

8.  Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease.

Authors:  Mary C Tassell; Rosari Kingston; Deirdre Gilroy; Mary Lehane; Ambrose Furey
Journal:  Pharmacogn Rev       Date:  2010-01

Review 9.  Polyphenolic Composition of Crataegus monogyna Jacq.: From Chemistry to Medical Applications.

Authors:  Seyed Fazel Nabavi; Solomon Habtemariam; Touqeer Ahmed; Antoni Sureda; Maria Daglia; Eduardo Sobarzo-Sánchez; Seyed Mohammad Nabavi
Journal:  Nutrients       Date:  2015-09-11       Impact factor: 5.717

10.  The combination of catechin and epicatechin callate from Fructus Crataegi potentiates beta-lactam antibiotics against methicillin-resistant staphylococcus aureus (MRSA) in vitro and in vivo.

Authors:  Rongxin Qin; Kangkang Xiao; Bin Li; Weiwei Jiang; Wei Peng; Jiang Zheng; Hong Zhou
Journal:  Int J Mol Sci       Date:  2013-01-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.